GlassScriptPhysician profile
Michelle Rc Smith
NPI 1346397262
$1,082.73
in general payments reported to CMS, 2019-2025
13 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $176 · 2020: $136 · 2021: $130 · 2022: $185 · 2023: $274 · 2024: $182.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $456.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $456.12 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Nevro Corp. | $233.49 | 2020-2022 | |
| Abbott Laboratories | $212.68 | 2019-2023 | Proclaim |
| Boston Scientific Corporation | $125.87 | 2020-2021 | |
| Amgen INC. | $113.71 | 2019 | |
| Abbvie INC. | $90.25 | 2023-2024 | Ubrelvy, Qulipta |
| Averitas Pharma INC. | $84.30 | 2024 | Qutenza |
| Pfizer INC. | $73.61 | 2023-2024 | |
| Biohaven Pharmaceuticals, INC. | $44.83 | 2021 | |
| Radius Health, INC. | $39.42 | 2021-2023 | Tymlos |
| Depuy Synthes Sales INC. | $19.45 | 2022 | |
| Davol INC. | $15.69 | 2019 | |
| Biohaven Pharmaceutical Holding Company LTD. | $15.51 | 2022 | |
| Ipsen Biopharmaceuticals, INC | $13.92 | 2024 | Dysport |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Michelle Smith listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.